BRJ Medical
BRJ Medical
Advanced clinical tools and consumables for global healthcare standards.
The global ophthalmic device market is currently undergoing a radical transformation, driven by a demographic shift toward an aging population and the increasing prevalence of age-related macular degeneration and cataracts. As a premier China Top Intraocular Devices Manufacturer, we observe a surge in demand for high-precision surgical instruments that provide "Information Gain" to surgeons—meaning devices that offer better intraoperative visibility and post-operative predictability.
The intraocular lens (IOL) market alone is projected to exceed USD 5.5 billion by 2028, with a CAGR of 6.2%.
Shift from PMMA to hydrophobic acrylic materials and the integration of AI-driven diagnostic tools.
High procurement growth in Asia-Pacific and Latin America for cost-effective, high-quality alternatives.
Founded in May 2004, Jiangsu BRJ Medical Co., Ltd. is a leading manufacturer specializing in the research, development, production, and distribution of high-quality surgical sutures, surgical needles, and other related medical instruments.
We are committed to providing a wide range of products that meet the highest quality standards both domestically and internationally. Our products comply with major certifications including CE, ISO 13485, ISO 14001, ISO 45001, and we hold all the necessary production licenses to meet global market requirements.
Efficiency Advantage: Our fully automated production systems have earned us 29 invention patents.
The manufacturing efficiency of Chinese medical factories provides unmatched competitive advantages.
From raw medical-grade polymers to micro-needle precision, China's Yangtze River Delta provides a condensed ecosystem that reduces lead times by 30-40% compared to Western counterparts.
Chinese manufacturers like Jiangsu BRJ Medical integrate feedback from surgeons rapidly, iterating product designs within months rather than years.
Maintaining CE and ISO 13485 standards while optimizing labor through automation allows us to offer premium ophthalmic solutions at sustainable prices for global public health systems.
To become a world-class leader in medical device manufacturing by consistently offering innovative, high-quality solutions that support healthcare professionals.
Integration of micro-sensors within IOLs to monitor intraocular pressure (IOP) in real-time, providing critical data for glaucoma management.
Advanced surface treatments for surgical needles and intraocular tools to minimize friction and tissue trauma, improving recovery times.
Transitioning toward sterile, eco-friendly, and compact packaging designs to reduce the carbon footprint of medical exports.
Devices designed to facilitate remote diagnosis and digital surgical planning, connecting local clinics with global experts.
Addressing the procurement needs of global healthcare distributors.
A: All our products, from surgical sutures to specialized instruments, are fully certified with CE, ISO 13485, ISO 14001, and ISO 45001. This ensures they meet the stringent regulatory requirements of the EU, Middle East, and Southeast Asian markets.
A: Yes, we specialize in high-capacity Private Label manufacturing. Our automated production lines and 29 invention patents allow us to customize specifications, packaging, and branding while maintaining consistent medical-grade quality.
A: We utilize advanced alloy materials and automated grinding technology. Every needle undergoes 100% optical inspection to ensure tip sharpness and structural integrity, crucial for delicate ophthalmic and cardiovascular procedures.
A: Due to our strategic location in Jiangsu and optimized supply chain, standard orders are typically fulfilled within 15-30 days, depending on customization requirements and volume.
Supporting diverse clinical applications with high-performance disposables and machines.
